Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant inter » significant interest (Expand Search), significant inverse (Expand Search), significant concern (Expand Search)
significant bias » significant based (Expand Search), significant gap (Expand Search), significant degs (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant inter » significant interest (Expand Search), significant inverse (Expand Search), significant concern (Expand Search)
significant bias » significant based (Expand Search), significant gap (Expand Search), significant degs (Expand Search)
-
2041
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2042
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2043
-
2044
-
2045
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2046
-
2047
-
2048
-
2049
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2050
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2051
-
2052
-
2053
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2054
-
2055
-
2056
-
2057
-
2058
-
2059
-
2060